Literature DB >> 32077065

Reliability and validity of Turkish version of pediatric balance scale.

Arzu Erden1, E Acar Arslan2, B Dündar3, M Topbaş4, U Cavlak3.   

Abstract

Assessment tool is a key point to evaluate balance disturbances in children. The aim of this study was to analyze reliability and validity of Turkish version of pediatric balance scale. The present study included 34 children (13 girls; 21 boys) with balance impairments. The scale consists of 14 items. Eight observers assessed the video records of the participants for interrater agreement. One observer evaluated the records twice in 2 weeks for intrarater agreement. Intraclass correlation coefficient was used for the interobserver and intraobserver agreement. The Functional Reach Test was used to calculate concurrent validity. Mean age of the sample was 11.68 ± 3.53 years. The Turkish version of the scale was found to be reliable, perfectly (intraclass correlation coefficient for interobserver agreement = 0.915). Intraobserver agreement was also reliable, perfectly (ICC = 0.927). The strong correlation between pediatric balance scale and functional reach test was found (r = 0.692; p < 0.001). The Turkish version of the scale is a valid and reliable tool to evaluate children with balance impairments. Moreover, it is easy to use for health providers working with disabled children.

Entities:  

Keywords:  Assessment; Balance; Children; Reliability and validity

Year:  2020        PMID: 32077065     DOI: 10.1007/s13760-020-01302-9

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  12 in total

1.  Validation of a model of gross motor function for children with cerebral palsy.

Authors:  R J Palisano; S E Hanna; P L Rosenbaum; D J Russell; S D Walter; E P Wood; P S Raina; B E Galuppi
Journal:  Phys Ther       Date:  2000-10

2.  Prevalence of vestibular and balance disorders in children.

Authors:  Robert C O'Reilly; Thierry Morlet; Brian D Nicholas; Gary Josephson; Drew Horlbeck; Larry Lundy; Arnel Mercado
Journal:  Otol Neurotol       Date:  2010-12       Impact factor: 2.311

3.  Validity and reliability of a pediatric reach test.

Authors:  Doreen Bartlett; Trevor Birmingham
Journal:  Pediatr Phys Ther       Date:  2003       Impact factor: 3.049

4.  Reliability and validity of the fine motor scale of the Peabody Developmental Motor Scales-2.

Authors:  Margo J van Hartingsveldt; Edith H C Cup; Rob A B Oostendorp
Journal:  Occup Ther Int       Date:  2005       Impact factor: 1.448

5.  Normal values of functional reach and lateral reach tests in children with knee hypermobility.

Authors:  Abhijeet A Deshmukh
Journal:  Pediatr Phys Ther       Date:  2014       Impact factor: 3.049

6.  Prevalence of vestibular and balance disorders in children and adolescents according to age: A multi-center study.

Authors:  Jong Dae Lee; Chang-Hee Kim; Seok Min Hong; Sung Huhn Kim; Myung-Whan Suh; Min-Beom Kim; Dae Bo Shim; Hosuk Chu; No Hee Lee; Minbum Kim; Sung Kwang Hong; Jae-Hyun Seo
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2017-01-11       Impact factor: 1.675

7.  Vertigo and balance problems in children--an epidemiologic study in Finland.

Authors:  Riina Niemensivu; Ilmari Pyykkö; Sylvette R Wiener-Vacher; Erna Kentala
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-08-15       Impact factor: 1.675

8.  Paroxysmal vertigo as a migraine equivalent in children: a population-based study.

Authors:  I Abu-Arafeh; G Russell
Journal:  Cephalalgia       Date:  1995-02       Impact factor: 6.292

9.  Epidemiology of Dizziness and Balance Problems in Children in the United States: A Population-Based Study.

Authors:  Chuan-Ming Li; Howard J Hoffman; Bryan K Ward; Helen S Cohen; Rose Marie Rine
Journal:  J Pediatr       Date:  2016-01-27       Impact factor: 4.406

10.  Application of the Gross Motor Function Measure-66 (GMFM-66) in Dutch clinical practice: a survey study.

Authors:  Laura W M E Beckers; Caroline H G Bastiaenen
Journal:  BMC Pediatr       Date:  2015-10-07       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.